How Entropy Neurodynamics Is Revolutionising Treatment for Binge Eating Disorder

• First patient fully dosed in world-first TRP-8803 IV psilocin trial for Binge Eating Disorder
• Three patients enrolled in 12-patient clinical trial with second patient dosing imminent
• $6.1 million capital raising completed to fund clinical, manufacturing, and regulatory activities
• Received $847k R&D tax incentive for FY24 with $1.73 million expected for FY25